Urquhart DS, Dowle H, Moffat K, Forster J, et al. Lung clearance index (LCI(2.5)) changes after initiation of Elexacaftor/Tezacaftor/Ivacaftor in children with cystic fibrosis aged between 6 and 11 years: The "real-world" differs from trial data. Pediatr Pulmonol 2024;59:1449-1453.
PMID: 38415920